C.R. Bard settles the 2nd bellwether personal injury lawsuit over its Avaulta pelvic mesh just before it was slated for trial, a week after a jury awarded $2 million in damages in the 1st trial.
C.R. Bard (NYSE:BCR) settled the 2nd bellwether trial over its Avaulta pelvic mesh just before it was supposed to go to trial, a week after losing a $2 million judgment in the 1st trial.
Murray Hill, N.J.-based Bard and plaintiff Wanda Queen agreed to settle the case on undisclosed terms, with lawyers notifying Judge Joseph Goodwin of the U.S. District Court for West Virginia that they’d agreed to settle the case yesterday on the morning it was set to go before a jury, according to news reports.
Last week a jury found that Bard’s Avaulta transvaginal mesh was defective, ruling that Bard failed to warn about the problems with the mesh, used to treat pelvic organ prolapse and stress urinary incontinence in women. The jury awarded $2 million in damages in that trial.
